Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-α

Circulation

Volumn 94, Issue 11, 1996, Pages 2787-2792

  Kaartinen, Maija ^a   Penttilä, Antti ^a   Kovanen, Petri T ^b  

^a WIHURI RESEARCH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

atherosclerosis; cells; coronary disease; cytokines

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; ATHEROMA; AUTOPSY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; LEFT CORONARY ARTERY; MALE; MAST CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0029848362     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.11.2787     Document Type: Article

References (27)

1. Kaartinen M, Penttilä A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation. 1994;90: 1669-1678.
2. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation. 1995;92:1084-1088.
3. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
4. Wong GHW, Goeddel DV. Tumor necrosis factor. In: Zembala M, Asherson GL, eds. Human Monocytes. San Diego, Calif: Academic Press; 1989:195-215.
5. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol. 1993;9:317-343.
6. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol. 1990;65:297-302.
7. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization. Am J Pathol. 1990;137:503-509.
8. Walsh LJ, Trichieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A. 1991;88:4220-4224.
9. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Hoearth PH, Holgate ST. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol. 1994;10:471-480.
10. Ohkavara Y, Yamauchi K, Tanno Y, Tamura G, Ohtari H, Nugura H, Ohkuda K, Takishima T. Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-α in sensitized lung tissue after IgE receptor triggering. Am J Respir Cell Mol Biol. 1992;7:385-392.
11. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature. 1990;346: 274-276.
12. Galli SJ. New concepts about the mast cell. N Engl J Med. 1993;328:257-265.
13. TC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem. 1989;37:1509-1515.
14. Kunkel SL, Remick DG, Stricter RM, Larrick JW. Mechanisms that regulate the production and effects of tumor necrosis factor-α. Crit Rev Immunol. 1989;9:93-117.
15. Libby P, Hansson GK. Involvement of the human immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 1991;64:5-15.
16. Stemme S, Hansson GK. Immune mechanisms in atherosclerosis. Coron Artery Dis. 1994;5:216-222.
17. Ishizaka T, Ishizaka K. Activation of mast cells for mediator release through IgE receptors. Prog Allergy. 1984;34:188-235.
18. Sedgwick JD, Holt PG, Turner KJ. Production of a histamine-releasing lymphokine by antigen- or mitogen-stimulated human peripheral T cells. Clin Exp Immunol. 1981;45:409-418.
19. Liu MC, Proud D, Lichtenstein LM, MacGlashan DW, Schleimer RP, Adkinson NF, Kagey-Sobotka A, Schulman ES, Flaut M. Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. J Immunol. 1986;136:2588-2595.
20. Rus HG, Niculescu F, Constantinescu E, Cristea A, Vlaicu R. Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque. Atherosclerosis. 1986;61:35-42.
21. Metcalfe DD, Kaliner M, Donlon DA. The mast cell. In: CRC Critical Reviews in Immunology. Boca Raton, Fla: CRC Press; 1981:23-74.
22. Collins T. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest. 1993;68:499-508.
23. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A. 1991;88:8154-8158.
24. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94: 2493-2503.
25. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM, Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation. 1995;91:2125-2131.
26. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN. Lark MW, Amento E, Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75:181-189.
27. Saren P, Welgus HG, Kovanen PT. Tumor necrosis factor-α and interleukin-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol. 1996;157:4159-4165.